Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update for abemaciclib in breast cancer. The study is currently active but not recruiting, and results were posted in March 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-03-30